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C BY-NC-Abstract A simple, accurate and highly sensitive spectrophotometric methods are proposed for the
rapid and accurate determination of amantadine HCl (AMD) using bromocressol green (BCG),
bromophenol blue (BPB) and bromothymol blue (BTB). The developed methods involve formation
of stable yellow colored chloroform extractable ion-associate complexes of the amino derivative
(basic nitrogen) of the AMD with three sulphonphthalein acid dyes, namely; BCG, BPB and
BTB, in acidic medium. The ion-associates exhibit absorption maxima at 415, 412 and 414 nm
for BCG, BPB and BTB, respectively. AMD can be determined up to 1.5–16.5, 1.4–14.0 and
1.6–17 lg mL1, respectively. The effect of optimum conditions via acidity, reagent concentration,
time, and solvent was studied. The stoichiometry of the reaction was found to be 1:1 in all cases.
The low relative standard deviation values indicate good precision and high recovery values. These
methods have been successfully applied for the assay of AMD in pharmaceutical formulations. Sta-
tistical comparison of the results with the reference method shows excellent agreement and indicates
no signiﬁcant difference in accuracy and precision.
ª 2010 King Saud University. Production and hosting by Elsevier B.V.o.com (H.A. Omara).
y. Production and hosting by
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ND license.1. Introduction
Amantadine (Scheme 1), an aliphatic tricyclic primary amine
(pKa = 10.1), is excreted predominantly unchanged into the ur-
ine and undergoes limited metabolism in man (Aoki and Sitar,
1988). Amantadine HCl (AMD) chemically, 1-adamantan-
amine hydrochloride, or known formally as 1-aminoadaman-
tane hydrochloride. The molecule consists of adamantane
backbone that is substituted at one of the four methyne posi-
tions with an amino group. This compound is sold under the
name ‘‘Symmetrel’’ for use both as an antiviral and an anti-Par-
kinsonian drug, against Asian inﬂuenza and eventually received
Scheme 1 The chemical structure of amantadine HCl.
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Figure 1 Absorption spectrum of ion-associate complexes of
AMD (10 lg mL1) with (1 · 103 M) BCG, BPB and BTB
against reagent blank.
76 H.A. Omara, A.S. Aminapproval for the treatment of inﬂuenza virus A (Moiseev et al.,
1976; Maugh, 1979) in adults, issued an alert to doctors not to
prescribe amantadine any more for the season. Among some
Asian countries, A/H3N2 and A/H1N1 resistance has reached
100% (Varough et al., 2007). Amantadine HCl is an antiviral
agent used against infection with inﬂuenza type A virus and
to ameliorate symptoms when administered during the early
stages of infection as well as in the management of herpes zoster
(Prud’homme et al., 1997). It has mild anti-Parkinsonism activ-
ity and thus it has been used in the management of Parkinson-
ism, mainly in the early disease stage and when the symptoms
are mild. AMD is usually given by mouth as the hydrochloride
salt (Martindale, 2002).
The analytical methods reported for AMD, included high-
performance liquid chromatography (Suckow et al., 1999; Fuj-
ino et al., 1993), liquid chromatography–mass spectrometry
(Wang et al., 2009), liquid chromatography–tandem mass
spectrometry (Arndt et al., 2005), Crystal structure and mass
spectrometry (Sotolarova et al., 2009), gas chromatography
(Leis et al., 2002), capillary electrophoresis (Reichova and
Pazourek, 2002), potentiometry (Abdel-Ghani et al., 2002),
and ﬂuorimetry (Darwish et al., 2005), Resonance Raman
spectroscopy (Stanic et al., 2001), NIR-spectroscopy (Dou
et al., 2005), Due to the absence of chromophores and/or
auxochromes in the amantadine molecule, it shows no distinct
absorption in the UV region above 200 nm. Therefore direct
UV spectrophotometry is not useful for its determination.
Few spectrophotometric methods (Omara and Amin, in press;
Darwish et al., 2005; Stanic et al., 2001; Dou et al., 2005; Sul-
tan, 2004; Rizk and Sultan, 2003; Darwish et al., 2006; Mah-
moud et al., 2009) have been reported for its determination.
These methods were sophisticated to perform and/or time
consuming.
Spectrophotometry is considered as the most convenient
analytical technique in pharmaceutical analysis because of its
inherent simplicity and availability in most quality control
and clinical laboratories (Amin et al., 2009a,b,c; Amin et al.,
2008; Gouda et al., 2008). However, AMD does not possess
any chromophore in its molecule, which is the essential
requirement for the direct or indirect spectrophotometric
analysis.
Bromocressol green (BCG), bromophenol blue (BPB) and
bromothymol blue (BTB) are known to yield an ion-pair com-
plex, which are applied in the determination of many pharma-
ceutical compounds (Naﬁsur et al., 2004; Naﬁsur and Syed,
2000; Amin et al., 2007; Sevgi, 2007; Gowda et al., 2001; Al-
Ghannam, 2006; Incilay and Ayla, 2002; Gouda et al., 2008;
Safwan and Raghad, 2005; Abdine et al., 2002; Faten et al.,
2006; Parvin et al., 2008; He´rida and Elfrides, 2001; Armag˘an,
2009; Hisham, 2007).The present work aims to present a simple, rapid and sen-
sitive method for the determination of AMD in pure form
and in their pharmaceutical preparations and can be used for
the quality control and assurance of these drugs in industry.
The methods are based on the formation of ion-associate be-
tween the cited drug and BCG, BPB or BTB. These methods
are very simple in applications and less expensive in compari-
son to the above-mentioned techniques, whereas at the same
time offering a high degree of accuracy and precision when
compared to the pharmacopoeia method and could be used
simply to determine the shelve stability time of the drug.
2. Experimental
2.1. Apparatus
All the spectral measurements were made using either Perkin
Elmer Lambda 12 or Perkin Elmer 73B spectrophotometers,
with scanning speed 400 nm/min and band width 2.0 nm,
equipped with 10 mm matched quartz cells. A centrifuge Mod-
el 90-1 with speed 50,000 rpm (USA) was used to carry out for
the spiked plasma samples.
2.2. Reagents and materials
All chemicals used were of analytical or pharmacopoeia grade
purity and doubly distilled water used. Standard amantadine
HCl was obtained from Egyptian Organization for Control
and Pharmaceutical Research, Cairo, Egypt.
The acid dye reagents BCG, BPB and BTB were obtained
from E. Merck Darmstdt F.R., Germany.
Standard solution 100 lg mL1 of amantadine HCl was
prepared by dissolving 10 mg of pure drug (pharmaceutical
grade) in the least amount of bidistilled water and made up
to 100 mL in measuring ﬂask with bidistilled water. The solu-
tion remained stable for 1 month when kept refrigerated.
Stock solution of bromocressol green (BCG), bromophenol
blue (BPB) and bromothymol blue (BTB) (1.0 · 103 M), were
prepared by dissolving 0.0698, 0.0670 and 0.0624 g, respec-
tively, in 100 mL acetone. The acid dye reagents were stable
for several weeks.
A 1.0 M solution of HCl was prepared by diluting appro-
priate volume of AnalaR stock solution to 100 mL measuring
Extractive-spectrophotometric methods for determination of anti-Parkinsonian 77ﬂask with bidistilled water and standardized as recommended
(Basset et al., 1978).
3. General procedure
Into a 50 mL separating funnel, a volume of amantadine HCl,
(0.1–2.0 mL) (100 lg mL1), 1.0, 1.2 and 1.0 mL (1 · 103 M)0.0
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Figure 2 Effect of shaking time on the ion-pair complexes.
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Figure 3 Job’s method of continuous variation graph for the
reaction of AMD with acid–dyes BCG, BPB and BTB, in
chloroform [drug] = [dye] = 1.0 · 103 M.
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Figure 4 Mole-ratio plots for the reaction of AMD with acid–
dyes BCG, BPB and BTB, in chloroform [drug] = [dye] =
1.0 · 103 M.of BCG, BPB and BTB, respectively. 1.0, 1.5 and 1.4 mL of
(1.0 M) HCl in the case of BCG, BPB and BTB, respectively.
The formed ion-associates were extracted with 4.0 mL chloro-
form after shaking for 2.0 min; the volume was made up to
10 mL with bidistilled water. The reaction mixture was allowed
to separate into two phases. The absorbance of the extracts
was measured at the recommended maximum wavelength
(415, 412 and 414 nm for BCG, BPB and BTB, respectively)Table 1 Optical and regression characteristics of AMD with
BCG, BPB and BTB.
Parameters BCG BPB BTB
kmax (nm) 415 412 414
Stability (h) 8 15 12
Shaking time (min) 2
Beer’s law limits (lg mL1) 1.5–16.5 1.4–14 1.6–17
Ringbom limits (lg mL1) 1.9–16 1.8–13.5 2.0–16.6
Molar absorptivity (L mol1 cm1) 1.51 · 104 1.84 · 104 1.65 · 104
Sandell sensitivity (ng cm2) 12.42 10.19 11.36
Detection limits (lg mL1) 0.093 0.063 0.089
Quantitation limits (lg mL1) 0.310 0.209 0.295
Regression equationa
Slope (b) 0.0805 0.0981 0.0880
RSD% of slope 0.0052 0.0031 0.0063
Intercept (a) 0.0023 0.0093 0.0011
RSD% of intercept 0.0039 0.0012 0.0055
Correlation coeﬃcient (r) 0.9998 0.9996 0.9997
Stoichiometric ratio 1:1 1:1 1:1
Range of error 0.57 0.67 0.61
RSD% 0.79 0.66 0.57
Calculated t-values (2.57)b 0.41 0.86 0.71
Calculated F-test (5.05)b 2.07 1.63 1.44
a With respect to A= a+ bC where C is concentration of drug
in lg mL1 and A is absorbance.
b Values in parentheses are the theoretical values for t- and F-
values at 95% conﬁdence limits and ﬁve degrees of freedom.
Table 2 Evaluation of the accuracy and precision of the
proposed procedure.
Reagent Taken
(lg mL1)
Recovery
(%)
RSDa
(%)
RE
(%)
Conﬁdence
limitsb
BCG 4.00 101.25 0.29 0.31 4.05 ± 0.0124
8.00 100.13 0.16 0.24 8.01 ± 0.0189
12.0 99.75 0.22 0.23 11.97 ± 0.0271
16.0 100.19 0.19 0.20 16.03 ± 0.0317
BPB 4.00 99.50 0.84 0.88 3.98 ± 0.0351
7.00 98.43 0.54 0.57 6.89 ± 0.0391
10.0 99.80 0.60 0.62 9.98 ± 0.0623
13.0 100.15 0.33 0.35 13.02 ± 0.0452
BTB 4.00 100.5 0.61 0.64 4.02 ± 0.0257
8.00 98.63 0.72 0.75 7.89 ± 0.0593
12.0 100.17 0.49 0.52 12.02 ± 0.0624
16.0 100.06 0.25 0.26 16.01 ± 0.0419
a Relative standard deviation for six determinations.
b 95% conﬁdence limits and ﬁve degrees of freedom.
78 H.A. Omara, A.S. Amin(Fig. 1), against a reagent blank prepared in the same manner
without the addition to the drug. All measurements were car-
ried out at room temperature (25 ± 2 C).
3.1. Determination of amantadine HCl in capsules
Twenty capsules carefully evacuated; their contents were
weighed and ﬁnely powdered. An accurately weighed quantity
of the capsule contents equivalent to 100 mg of AMD was
transferred into a 100 mL calibrated ﬂask, and dissolved in
about 40 mL of distilled water. The contents of the ﬂask were
swirled, sonicated for 5.0 min, and then completed to volume
with water. The contents were mixed well and ﬁltered rejecting
the ﬁrst portion of the ﬁltrate. The prepared solution was di-
luted quantitatively with distilled water to obtain a suitable
concentration for the analysis.
3.2. Procedure for spiked plasma samples
Aliquots of 1.0 mL of plasma spiked with different concentra-
tion levels of AMD. The spiked plasma samples treated with
0.1 mL of 70% perchloric acid and vortexed for 1.0 min. The
samples centrifuged for 20 min at 13,000 rpm. The superna-
tants transferred into test tubes and neutralized with
1.0 mol L1 NaOH solution.4. Results and discussion
Several parameters such as acidity, type and amount of acid
added, reagent concentration, sequence of addition and effect
of extracting solvent were optimized to achieve high sensitivity,
stability, low blank reading and reproducible results.Table 3 Determination of AMD in pharmaceutical formulations u
Samples Taken
(lg mL1)
Added
(lg mL1)
BCG
Founda
(lg mL1)
R
(%
Amantine 100 mgb 5.0 0.0 5.02 10
2.0 6.97 9
4.0 8.95 9
6.5 11.49 9
PK-Pmerz 100 mgc 4.0 0.0 3.98 9
3.0 6.98 9
6.0 9.97 9
9.0 13.02 10
Viraﬂu 100 mgd 3.0 0.0 3.01 10
1.0 4.02 10
4.0 6.94 9
8.0 10.99 9
Spiked human
plasma
2.0 0.0 1.99 9
3.5 5.48 9
7.0 9.02 10
12.0 13.93 9
a Average of six determinations.
b Memphis Pharmaceutical & Chemicals Industries Company, Cairo, E
c Merz Pharma GmbH & Co., KGaA Frankfurt/Main, Germany.
d Sigma Pharmaceutical Industries Company, El-Monofeya, Egypt.4.1. Effect of acidity
In a trial to elucidate the optimum medium for the quantitative
determination of AMD, the effect of sulphoric, acetic and
hydrochloric acids was examined. The highest absorbance va-
lue was obtained in the presence of 1.0 M HCl. It was found
that on using 1.0, 1.5 and 1.4 mL of 1.0 M HCl in the case
of BCG, BPB and BTB, maximum absorbance values and high
stability were achieved.
4.2. Effect of the reagent concentration
The effect of reagent concentration was tested by using
amounts (0.1–2.0 mL) of 1.0 · 103 M solution of each reagent
with 10 lg mL1 of AMD. The results showed that 1.0, 1.2
and 1.0 mL of BCG, BPB and BTB, respectively, were sufﬁ-
cient for the production of maximum and reproducible color
intensity.
4.3. Effect of sequence of mixing
The most favorable sequence was (reagent–drug–acid) for the
production of highest color intensity and the shortest time
for developing maximum absorbance, while the other sequence
required longer time and produced lower absorbance values.
4.4. Effect of shaking time and temperature
The effect of shaking time and temperature on the formation
and stability of the ion-associates was studied by measuring
the absorbance of the extracted ion-associates at increasing
time intervals, the results showed that the ion-associates weresing standard addition technique.
BPB BTB
ecovery
)
Founda
(lg mL1)
Recovery
(%)
Founda
(lg mL1)
Recovery
(%)
0.40 4.99 99.80 5.01 100.20
9.57 7.01 100.14 6.99 99.86
9.44 9.02 100.22 8.98 99.78
9.91 11.52 100.17 11.51 100.09
9.50 3.99 99.75 4.01 100.25
9.71 7.01 100.14 6.99 99.86
9.70 10.01 100.10 9.98 99.80
0.15 12.98 99.85 13.02 100.15
0.33 3.00 100.0 2.99 99.67
0.50 3.99 99.75 3.98 99.50
9.14 6.99 99.86 7.02 100.29
9.91 11.01 100.09 11.03 100.27
9.50 2.01 100.50 2.01 100.50
9.64 5.51 100.18 5.49 99.82
0.22 8.97 99.67 8.99 99.89
9.50 14.01 100.07 13.97 99.79
gypt.
Extractive-spectrophotometric methods for determination of anti-Parkinsonian 79formed almost instantaneously in all cases at room tempera-
ture (25 ± 2 C) with 2.0 min shaking time (Fig. 2). The devel-
oped color remained stable for 8, 15 and 12 h using BCG, BPB
and BTB, receptively. After these intervals, a slight decrease in
color intensity occurred.
4.5. Effect of extracting solvent
The polarity of the solvents affects both extraction efﬁciency
and absorptivity of the ion associates. Several water-immisci-
ble organic solvents including benzene, toluene, carbon tetra-
chloride, chloroform, methylene chloride, 1,2-dichloroethane
and nitrobenzene were tried. The most convenient solvent
found to produce the highest absorbance, extraction power
and stability of color of the formed ion-associates was chloro-
form for BCG, BPB and BTB. The study revealed that a vol-
ume ratio of 3:2 (aqueous:organic) was the most suitable for
the ion-associate extraction.
4.6. The stoichiometric ratio of the ion-associate
The stoichiometry of the ion-associates formed between the
drug and the reagents was investigated by applying the contin-Table 4 Determination of AMD in capsules (100 mg/capsule) and
Parameter BCG BP
Amantine 100 mga
Recovery (%)b 100.2 ± 1.1 99
±Standard deviation 0.66 0.
Number of experiments 6 6
Variance 0.71 0.
Student t-valuec 1.93 0.
Variance ratio F-testc 1.82 2.
PK-Pmerz 100 mgd
Recovery (%)b 99.8 ± 0.71 99
±Standard deviation 0.71 0.
Number of experiments 6 6
Variance 0.55 0.
Student t-valuec 0.66 0.
Variance ratio F-testc 1.74 2.
Viraﬂu 100 mge
Recovery (%)b 100.1 ± 1.2 99
±Standard deviation 0.99 1.
Number of experiments 6 6
Variance 0.43 1.
Student t-valuec 0.80 1.
Variance ratio F-testc 3.12 3.
Spiked plasma pimples
Recovery (%)b 99.5 ± 0.61 99
±Standard deviation 0.54 0.
Number of experiments 6 6
Variance 1.04 0.
Student t-valuec 1.57 1.
Variance ratio F-testc 2.77 2.
a Memphis Pharmaceutical & Chemicals Industries Company, Cairo, E
b Average values of six determinations were used for the ofﬁcial and th
c Theoretical values for t and F at 95% conﬁdence limit are 2.57 and 5
d Merz Pharma GmbH & Co., KGaA Frankfurt/Main, Germany.
e Sigma Pharmaceutical Industries Company, El-Monofeya, Egypt.uous variation (Job, 1928) (Fig. 3) and the molar ratio (Fig. 4)
(Yoe and Jones, 1944) methods at the wavelengths of maxi-
mum absorbance. The results obtained showed that the stoi-
chiometric ratio of the ion-associates is 1:1 (reagent:drug) in
all cases.
4.7. Analytical data
Beer’s law was veriﬁed up to (1.5–16.5), (1.4–14) and (1.6–
17) lg mL1 of AMD with BCG, BPB and BTB, respectively.
The molar absorptivity (e) was calculated and found to be
1.51 · 104, 1.84 · 104 and 1.65 · 104 L mol1 cm1, with
BCG, BPB and BTB, respectively, indicating high sensitivity
of the reagents under investigations for the determination of
AMD. The limits of detection (K= 3) and quantitation
(K= 10) were established according to IUPAC deﬁnitions
(IUPAC, 1978) are recorded in Table 1. The regression equa-
tions (A= a+ bC) where A= absorbance, a= intercept,
b= slope and C= concentration in lg mL1, calculated from
the calibration graph, were evaluated and recorded in Table 1.
The intercept of the lines was very small indicating that there is
no systematic difference between determined and expected
concentration within the investigated range using the presentspiked plasma by the proposed and ofﬁcial method [PB, 2007].
B BTB Oﬃcial
.7 ± 0.29 99.9 ± 0.49 99.5 ± 1.0
94 1.01 1.13
6 6
59 0.47 1.19
88 1.33 1.42
55 3.11 2.32
.7 ± 1.2 100.1 ± 0.8 99.3 ± 0.86
76 0.84 0.94
6 6
49 0.37 1.17
92 0.87 1.21
03 1.69 2.19
.6 ± 0.63 100 ± 1.31 99.2 ± 0.53
01 0.55 1.21
6 6
05 0.49 1.19
22 0.73 0.78
05 2.86 3.22
.9 ± 1.31 100.1 ± 1.3 99.3 ± 0.92
96 1.02 1.41
6 6
68 0.63 1.32
39 0.93 1.17
41 3.04 2.66
gypt.
e proposed methods, respectively.
.05, respectively.
80 H.A. Omara, A.S. Aminmethod. For more accurate results, Ringbom concentration
range was determined by plotting log[drug] in lg mL1 against
% transmittance from which the linear portion of the curve
gave accurate range for the determination of the drug under
investigation (Table 1). In order to determine the accuracy
and precision of the present method, solutions containing ﬁve
different concentrations of drug were prepared and six repli-
cate determinations, converting the usable concentration
range, were carried out for the pure form and the pharmaceu-
tical of the drugs under investigation. The recovery values al-
most reach 100% recovery, revealing a high accuracy of the
results (Table 2). The calculated standard deviations are com-
pared with those obtained by the pharmacopoeia method of
amantadine HCl (The British Pharmacopoeia (BP), 2007)
based on (potentiometric titration, using 0.1 M sodium
hydroxide. Each milliliter of 0.1 M sodium hydroxide is equiv-
alent to 18.77 mg of AMD). The proposed method was suc-
cessfully applied to determine AMD in its dosage forms and
in spiked serum plasma. The accuracy of the proposed meth-
ods is evaluated by applying standard addition technique, in
which variable amounts of the drug were added to the previ-
ously analyzed portion of pharmaceutical preparations and
in spiked serum plasma. The results recorded in Table 3, were
compared statistically with the ofﬁcial method by Student’s t-
test (for accuracy), and variance ratio F-test (for precision)
(Miller and Miller, 1993), at 95% conﬁdence level as recorded
in Table 4. Such comparison showed that there is no signiﬁcant
difference, at 25% conﬁdence level, between the values ob-
tained by the proposed and the pharmacopoeia method. This
indicates the high accuracy and precision of the present
method.
4.8. Interference
A systematic qualitative study was undertaken by measuring
the absorbance of solutions containing 1.0 mL of 100 lg mL1
drug together with varying excess of different additives and
excipients which may be present in the pharmaceutical prepa-
rations using the recommended methods of such reagents. No
signiﬁcant interference was observed from the excipients com-
monly used such as glucose, micro-crystalline cellulose, lac-
tose, fructose, starch and magnesium stearate; this shows
that the method is applicable in the case of pharmaceutical
preparations of the drug.5. Conclusions
The proposed method for the estimation of amantadine HCl
using bromocressol green, bromophenol blue and bromothy-
mol blue is advantageous over many of the reported methods
due to its sensitivity, rapidity and good agreement with the
pharmacopoeia methods. The high recovery percentage and
low relative standard deviation reﬂect the high accuracy and
precision of the proposed method. Moreover, the method is
easy, applicable to wide ranges of concentration, besides less
time consuming and depend on simple reagents which are
available. This offers economic and acceptable method for
the routine determination of the cited drug. So, it is recom-
mended for the routine determination in pure samples and in
their pharmaceutical formulations.References
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